Loading...

Marie Dell'Aquila

TitleClinical Professor
InstitutionUniversity of California San Diego
DepartmentMedicine
Address9300 Campus Point Drive #7181
La Jolla CA 92037
Phone858-657-5742
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Dell’Aguila is Director of the Cytogenetic Laboratory, a ABMG Certified Clinical Cytogeneticist, and Clinical Professor of Medicine at the University of California, San Diego (UCSD).


    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wang HY, Dell'Aquila ML, Dvanajscak Z, Bejar R, Broome HE, Hsi E, Murray SS, Thorson JA. JAK2 double minutes with resultant simultaneous amplification of JAK2 and CD274 in a therapy-related myelodysplastic syndrome evolving into an acute myeloid leukaemia. Br J Haematol. 2018 Aug 21. PMID: 30132795.
      View in: PubMed
    2. Zare SY, Lin L, Alghamdi AG, Daehne S, Roma AA, Hasteh F, Dell'Aquila M, Fadare O. Breast cancers with HER2/CEP17 ratio = 2.0 and an average HER2 copy number <4.0 per cell: frequency, Immunohistochemical correlation, and Clinicopathologic features. Hum Pathol. 2018 Aug 16. PMID: 30121371.
      View in: PubMed
    3. Zare S, Lin L, Alghamdi AG, Daehne S, Roma AA, Hasteh F, Dell'Aquila M, Fadare O. Comparative Pathologic Analysis of Breast Cancers Classified as HER2/neu-Amplified by FISH Using a Standard HER2/CEP17 Dual Probe and an Alternative Chromosome 17 Control Probe. Am J Surg Pathol. 2018 Jun 19. PMID: 29923906.
      View in: PubMed
    4. Solomon JP, Dell'Aquila M, Fadare O, Hasteh F. Her2/neu Status Determination in Breast Cancer: A Single Institutional Experience Using a Dual-Testing Approach With Immunohistochemistry and Fluorescence In Situ Hybridization. Am J Clin Pathol. 2017 Apr 01; 147(4):432-437. PMID: 28340220.
      View in: PubMed
    5. Nguyen JC, Kubik MJ, Broome HE, Curtin PT, Dell'Aquila ML, Wang HY. Successful treatment of both double minute of C-MYC and BCL-2 rearrangement containing large B-cell lymphoma with subsequent unfortunate development of therapy-related acute myeloid leukemia with t(3;3)(q26.2;q21). Pathol Res Pract. 2015 Nov; 211(11):883-91. PMID: 26300063.
      View in: PubMed
    6. Li K, Johnson RL, Li S, Thorson JA, Mulroney CM, Dell'Aquila ML, Wang HY. Nodal involvement by marginal zone B-cell lymphoma harboring t(14;22)(q32;q11) involving immunoglobulin heavy chain and light chain lambda as the sole karyotypically recognizable abnormality in a patient with systemic lupus erythematosus. Int J Clin Exp Pathol. 2014; 7(8):5221-31. PMID: 25197401; PMCID: PMC4152091.
    7. Acunzo M, Romano G, Wernicke D, Balatti V, Rassenti LZ, dell'Aquila M, Kipps TJ, Pekarsky Y, Croce CM. Translocation t(2;11) in CLL cells results in CXCR4/MAML2 fusion oncogene. Blood. 2014 Jul 10; 124(2):259-62. PMID: 24855209; PMCID: PMC4093682.
    8. Xu X, Su M, Levy NB, Mohtashamian A, Monaghan S, Kaur P, Zaremba C, Garcia R, Broome HE, Dell'Aquila ML, Wang HY. Myeloid neoplasm with t(3;8)(q26;q24): report of six cases and review of the literature. Leuk Lymphoma. 2014 Nov; 55(11):2532-7. PMID: 24397594.
      View in: PubMed
    9. Wang HY, Thorson JA, Broome HE, Rashidi HH, Curtin PT, Dell'Aquila ML. t(4;22)(q12;q11.2) involving presumptive platelet-derived growth factor receptor A and break cluster region in a patient with mixed phenotype acute leukemia. Hum Pathol. 2011 Dec; 42(12):2029-36. PMID: 21676437.
      View in: PubMed
    10. Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S, Barbarotto E, Cimmino A, Adair B, Wojcik SE, Valeri N, Calore F, Sampath D, Fanini F, Vannini I, Musuraca G, Dell'Aquila M, Alder H, Davuluri RV, Rassenti LZ, Negrini M, Nakamura T, Amadori D, Kay NE, Rai KR, Keating MJ, Kipps TJ, Calin GA, Croce CM. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA. 2011 Jan 05; 305(1):59-67. PMID: 21205967; PMCID: PMC3690301.
    11. Xu X, Broome EH, Rashidi HH, South ST, Dell'aquila ML, Wang HY. CD20dim-positive T-cell large granular lymphocytic leukemia in a patient with concurrent hairy cell leukemia and plasma cell myeloma. Int J Clin Exp Pathol. 2010 Sep 12; 3(8):798-807. PMID: 21151394; PMCID: PMC2993231.
    12. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, Dell'Aquila ML, Alder H, Rassenti L, Kipps TJ, Bullrich F, Negrini M, Croce CM. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A. 2004 Aug 10; 101(32):11755-60. PMID: 15284443; PMCID: PMC511048.